Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-265
Closed -$15K – 2296
2018
Q4
$15K Buy
+265
New +$14.4K ﹤0.01% 1814
2018
Q2
$1.29M Hold
26,719
– – ﹤0.01% 1197
2018
Q1
$1.16M Buy
26,719
+15,474
+138% +$695K ﹤0.01% 1177
2017
Q4
$447K Buy
11,245
+373
+3% +$15.5K ﹤0.01% 1399
2017
Q3
$472K Sell
10,872
-2,746
-20% -$125K ﹤0.01% 1380
2017
Q2
$652K Buy
13,618
+13,614
+340,350% +$635K ﹤0.01% 1325
2017
Q1
$1K Buy
+4
New +$167 ﹤0.01% 2106
2016
Q3
– Sell
-2,394
Closed -$103K – 2205
2016
Q2
$103K Buy
2,394
+2,310
+2,750% +$96.9K ﹤0.01% 1555
2016
Q1
$4K Sell
84
-11,061
-99% -$532K ﹤0.01% 1921
2015
Q4
$706K Sell
11,145
-3,241
-23% -$221K ﹤0.01% 1198
2015
Q3
$942K Buy
+14,386
New +$955K ﹤0.01% 1112

Federated Hermes's IMPV Position: Q1 2019 in Review

Federated Hermes sold out of Imperva (IMPV) in Q1 2019, closing a stake of 265 shares — an estimated $15K sold.

Federated Hermes first reported a position in IMPV in Q3 2015 and held it in 11 quarters. The position peaked at $1.29M in Q2 2018. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.

  • Federated Hermes reported no remaining Imperva position as of Q1 2019 after selling out during the quarter.
  • Federated Hermes sold 265 Imperva shares in Q1 2019, an estimated $15K.
  • Federated Hermes first reported a position in Imperva in Q3 2015 and held it in 11 quarters.
  • Federated Hermes's Imperva position peaked at $1.29M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Imperva as of Q1 2019.

Based on Federated Hermes's 13F filing for Q1 2019, filed 10 May 2019.